+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Pharmaceutical Gelatin Market by Source, Type, Form, Application, Distribution Channel - Global Forecast to 2030

  • PDF Icon

    Report

  • 190 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5201060
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The pharmaceutical gelatin market is undergoing a period of substantial transformation, defined by advanced manufacturing requirements, increased regulatory oversight, and intensified emphasis on supply chain integrity. Senior decision-makers now seek clarity on the evolving forces and actionable trends shaping this complex global industry landscape.

Market Snapshot: Pharmaceutical Gelatin Market Outlook

The pharmaceutical gelatin market grew from USD 1.28 billion in 2024 to USD 1.36 billion in 2025. The market is expected to expand at a CAGR of 6.47%, reaching USD 1.87 billion by 2030. This growth is being propelled by the shift toward higher purity requirements, advanced excipient functionalities, and increased consumption across specialized drug delivery systems. Stakeholders are recalibrating supply chains and investing in sourcing resilience to meet the demands of increasingly complex pharmaceutical formulations. The primary keyword, pharmaceutical gelatin market, frames these dynamics as central concerns for executive strategy.

Scope & Segmentation of the Pharmaceutical Gelatin Market

  • Source: Bovine, fish, and porcine origins define performance and compliance, impacting formulation suitability and addressing allergen and cultural considerations.
  • Type: Type A and Type B gelatins are differentiated by processing and isoelectric points, informing selection for tailored drug delivery needs.
  • Form: Powder and sheet formats each deliver manufacturing advantages, such as rapid dissolution or uniformity for specific pharmaceutical processes.
  • Application: Hard capsules, pellets, soft capsules, and tablet coatings leverage gelatin’s unique mechanical and barrier properties to meet drug stability and release profiles.
  • Distribution Channel: Direct, distributor, and online platforms each offer distinctive advantages for procurement, risk management, and logistics efficiency.
  • Regions: Americas, Europe, Middle East & Africa, and Asia-Pacific reflect regulatory diversity, supply chain considerations, and demand drivers. Key countries include United States, Canada, Brazil, United Kingdom, Germany, China, India, and Japan.
  • Companies: Major industry participants include Darling Ingredients Inc., Gelita AG, Nitta Gelatin Inc., PB Leiner NV, Nippi Inc., Weishardt International SAS, Tessenderlo Group NV, Danish Crown Protein A/S, Italgelatin SpA, and MV Protein Inc.

Key Takeaways for Senior Decision-Makers

  • Technological advancements in process analytics enhance batch consistency and support the production of high-purity pharmaceutical gelatins for emerging drug delivery systems.
  • Regulatory agencies increasingly demand rigorous traceability and validation measures, driving investments in digital monitoring, supply chain transparency, and supplier auditing platforms.
  • Sustainability imperatives are accelerating interest in marine-derived and recombinant alternatives, with companies exploring new sources to diversify risk and meet environmental benchmarks.
  • Competitive dynamics favor both global producers with extensive infrastructure and regional specialists delivering niche functionalities and localized technical support.
  • Formulation partnerships and vertical integration strategies increase control over excipient quality while addressing precision requirements for biologics and controlled-release products.
  • Online distribution channels provide procurement flexibility and bring efficiency to negotiation and logistics—critical in a landscape defined by resource volatility and shifting buyer preferences.

Tariff Impact: Recalibrating Global Supply Chains

Recent U.S. tariffs on selected pharmaceutical raw materials have driven manufacturers to reassess sourcing strategies, with particular focus on bovine-derived gelatin. Global producers are responding by enhancing capacity in unaffected regions and diversifying supplier networks. End users are renegotiating contract structures and spreading procurement risk, which fosters collaboration focused on cost control and supply continuity. These tariff-induced shifts are not just short-term responses but are realigning longer-term industry relationships and resilience strategies.

Methodology & Data Sources

This research integrates primary interviews with industry stakeholders, including gelatin producers, pharmaceutical formulators, and regulatory experts. Methodologies include secondary analysis from relevant publications, patent reviews, and pharmacopoeial standards. Quantitative market intelligence is constructed through supply chain tracking, production capacity data, and trade flow analysis, cross-validated by peer review for robust accuracy.

Why This Report Matters

  • Enables strategic planning by delivering actionable segmentation, supplier landscapes, and insight into regulatory and tariff-driven disruptions.
  • Supports risk mitigation by highlighting global sourcing alternatives, supply chain transparency practices, and digital tracking innovations.
  • Provides benchmarking intelligence for competitive and regional positioning in key growth markets and application segments.

Conclusion

The pharmaceutical gelatin market is shaped by the interplay of innovation, regulation, and supply chain adaptation. Informed strategies incorporating segmentation depth and resilience enable decision-makers to respond confidently to market evolution and emerging requirements.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Pharmaceutical Gelatin Market, by Source
8.1. Introduction
8.2. Bovine
8.3. Fish
8.4. Porcine
9. Pharmaceutical Gelatin Market, by Type
9.1. Introduction
9.2. Type a
9.3. Type B
10. Pharmaceutical Gelatin Market, by Form
10.1. Introduction
10.2. Powder
10.3. Sheet
11. Pharmaceutical Gelatin Market, by Application
11.1. Introduction
11.2. Hard Capsule
11.3. Pellets
11.4. Soft Capsule
11.5. Tablet Coating
12. Pharmaceutical Gelatin Market, by Distribution Channel
12.1. Introduction
12.2. Direct
12.3. Distributor
12.4. Online
13. Americas Pharmaceutical Gelatin Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Pharmaceutical Gelatin Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Pharmaceutical Gelatin Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Darling Ingredients Inc.
16.3.2. Gelita AG
16.3.3. Nitta Gelatin Inc.
16.3.4. PB Leiner NV
16.3.5. Nippi Inc.
16.3.6. Weishardt International SAS
16.3.7. Tessenderlo Group NV
16.3.8. Danish Crown Protein a/S
16.3.9. Italgelatin SpA
16.3.10. MV Protein Inc.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. PHARMACEUTICAL GELATIN MARKET MULTI-CURRENCY
FIGURE 2. PHARMACEUTICAL GELATIN MARKET MULTI-LANGUAGE
FIGURE 3. PHARMACEUTICAL GELATIN MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY FORM, 2024 VS 2030 (%)
FIGURE 12. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY FORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 16. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS PHARMACEUTICAL GELATIN MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS PHARMACEUTICAL GELATIN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES PHARMACEUTICAL GELATIN MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES PHARMACEUTICAL GELATIN MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GELATIN MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GELATIN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC PHARMACEUTICAL GELATIN MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC PHARMACEUTICAL GELATIN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. PHARMACEUTICAL GELATIN MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. PHARMACEUTICAL GELATIN MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. PHARMACEUTICAL GELATIN MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY BOVINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY FISH, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY PORCINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE A, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE B, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY POWDER, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY SHEET, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY HARD CAPSULE, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY PELLETS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY SOFT CAPSULE, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY TABLET COATING, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY DIRECT, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY DISTRIBUTOR, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY ONLINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. AMERICAS PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 26. AMERICAS PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 27. AMERICAS PHARMACEUTICAL GELATIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 28. AMERICAS PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 29. AMERICAS PHARMACEUTICAL GELATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 30. AMERICAS PHARMACEUTICAL GELATIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 31. UNITED STATES PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 32. UNITED STATES PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 33. UNITED STATES PHARMACEUTICAL GELATIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 34. UNITED STATES PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 35. UNITED STATES PHARMACEUTICAL GELATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 36. UNITED STATES PHARMACEUTICAL GELATIN MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 37. CANADA PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 38. CANADA PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 39. CANADA PHARMACEUTICAL GELATIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 40. CANADA PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 41. CANADA PHARMACEUTICAL GELATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 42. MEXICO PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 43. MEXICO PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 44. MEXICO PHARMACEUTICAL GELATIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 45. MEXICO PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 46. MEXICO PHARMACEUTICAL GELATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 47. BRAZIL PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 48. BRAZIL PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 49. BRAZIL PHARMACEUTICAL GELATIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 50. BRAZIL PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 51. BRAZIL PHARMACEUTICAL GELATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 52. ARGENTINA PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 53. ARGENTINA PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 54. ARGENTINA PHARMACEUTICAL GELATIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 55. ARGENTINA PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 56. ARGENTINA PHARMACEUTICAL GELATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 57. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 58. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 59. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GELATIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 60. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 61. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GELATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 62. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GELATIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 63. UNITED KINGDOM PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 64. UNITED KINGDOM PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 65. UNITED KINGDOM PHARMACEUTICAL GELATIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 66. UNITED KINGDOM PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 67. UNITED KINGDOM PHARMACEUTICAL GELATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 68. GERMANY PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 69. GERMANY PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 70. GERMANY PHARMACEUTICAL GELATIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 71. GERMANY PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 72. GERMANY PHARMACEUTICAL GELATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 73. FRANCE PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 74. FRANCE PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 75. FRANCE PHARMACEUTICAL GELATIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 76. FRANCE PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 77. FRANCE PHARMACEUTICAL GELATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 78. RUSSIA PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 79. RUSSIA PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 80. RUSSIA PHARMACEUTICAL GELATIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 81. RUSSIA PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 82. RUSSIA PHARMACEUTICAL GELATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 83. ITALY PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 84. ITALY PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 85. ITALY PHARMACEUTICAL GELATIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 86. ITALY PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 87. ITALY PHARMACEUTICAL GELATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 88. SPAIN PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 89. SPAIN PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 90. SPAIN PHARMACEUTICAL GELATIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 91. SPAIN PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 92. SPAIN PHARMACEUTICAL GELATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 93. UNITED ARAB EMIRATES PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 94. UNITED ARAB EMIRATES PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 95. UNITED ARAB EMIRATES PHARMACEUTICAL GELATIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 96. UNITED ARAB EMIRATES PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 97. UNITED ARAB EMIRATES PHARMACEUTICAL GELATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 98. SAUDI ARABIA PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 99. SAUDI ARABIA PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 100. SAUDI ARABIA PHARMACEUTICAL GELATIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 101. SAUDI ARABIA PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 102. SAUDI ARABIA PHARMACEUTICAL GELATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 103. SOUTH AFRICA PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 104. SOUTH AFRICA PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 105. SOUTH AFRICA PHARMACEUTICAL GELATIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 106. SOUTH AFRICA PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 107. SOUTH AFRICA PHARMACEUTICAL GELATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 108. DENMARK PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 109. DENMARK PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 110. DENMARK PHARMACEUTICAL GELATIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 111. DENMARK PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 112. DENMARK PHARMACEUTICAL GELATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 113. NETHERLANDS PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 114. NETHERLANDS PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 115. NETHERLANDS PHARMACEUTICAL GELATIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 116. NETHERLANDS PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 117. NETHERLANDS PHARMACEUTICAL GELATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 118. QATAR PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 119. QATAR PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 120. QATAR PHARMACEUTICAL GELATIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 121. QATAR PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 122. QATAR PHARMACEUTICAL GELATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 123. FINLAND PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 124. FINLAND PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 125. FINLAND PHARMACEUTICAL GELATIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 126. FINLAND PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 127. FINLAND PHARMACEUTICAL GELATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 128. SWEDEN PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 129. SWEDEN PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 130. SWEDEN PHARMACEUTICAL GELATIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 131. SWEDEN PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 132. SWEDEN PHARMACEUTICAL GELATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 133. NIGERIA PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 134. NIGERIA PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 135. NIGERIA PHARMACEUTICAL GELATIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 136. NIGERIA PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 137. NIGERIA PHARMACEUTICAL GELATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 138. EGYPT PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 139. EGYPT PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 140. EGYPT PHARMACEUTICAL GELATIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 141. EGYPT PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 142. EGYPT PHARMACEUTICAL GELATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 143. TURKEY PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 144. TURKEY PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 145. TURKEY PHARMACEUTICAL GELATIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 146. TURKEY PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 147. TURKEY PHARMACEUTICAL GELATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 148. ISRAEL PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 149. ISRAEL PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 150. ISRAEL PHARMACEUTICAL GELATIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 151. ISRAEL PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 152. ISRAEL PHARMACEUTICAL GELATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 153. NORWAY PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 154. NORWAY PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 155. NORWAY PHARMACEUTICAL GELATIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 156. NORWAY PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 157. NORWAY PHARMACEUTICAL GELATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 158. POLAND PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 159. POLAND PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 160. POLAND PHARMACEUTICAL GELATIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 161. POLAND PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 162. POLAND PHARMACEUTICAL GELATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 163. SWITZERLAND PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 164. SWITZERLAND PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 165. SWITZERLAND PHARMACEUTICAL GELATIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 166. SWITZERLAND PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 167. SWITZERLAND PHARMACEUTICAL GELATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 168. ASIA-PACIFIC PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 169. ASIA-PACIFIC PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 170. ASIA-PACIFIC PHARMACEUTICAL GELATIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 171. ASIA-PACIFIC PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 172. ASIA-PACIFIC PHARMACEUTICAL GELATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 173. ASIA-PACIFIC PHARMACEUTICAL GELATIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 174. CHINA PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 175. CHINA PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 176. CHINA PHARMACEUTICAL GELATIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 177. CHINA PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 178. CHINA PHARMACEUTICAL GELATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 179. INDIA PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 180. INDIA PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 181. INDIA PHARMACEUTICAL GELATIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 182. INDIA PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 183. INDIA PHARMACEUTICAL GELATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 184. JAPAN PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 185. JAPAN PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 186. JAPAN PHARMACEUTICAL GELATIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 187. JAPAN PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 188. JAPAN PHARMACEUTICAL GELATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 189. AUSTRALIA PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 190. AUSTRALIA PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 191. AUSTRALIA PHARMACEUTICAL GELATIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 192. AUSTRALIA PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 193. AUSTRALIA PHARMACEUTICAL GELATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 194. SOUTH KOREA PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 195. SOUTH KOREA PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 196. SOUTH KOREA PHARMACEUTICAL GELATIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 197. SOUTH KOREA PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 198. SOUTH KOREA PHARMACEUTICAL GELATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 199. INDONESIA PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 200. INDONESIA PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 201. INDONESIA PHARMACEUTICAL GELATIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 202. INDONESIA PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 203. INDONESIA PHARMACEUTICAL GELATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 204. THAILAND PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 205. THAILAND PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 206. THAILAND PHARMACEUTICAL GELATIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 207. THAILAND PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 208. THAILAND PHARMACEUTICAL GELATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 209. PHILIPPINES PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 210. PHILIPPINES PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 211. PHILIPPINES PHARMACEUTICAL GELATIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 212. PHILIPPINES PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 213. PHILIPPINES PHARMACEUTICAL GELATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 214. MALAYSIA PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 215. MALAYSIA PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 216. MALAYSIA PHARMACEUTICAL GELATIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 217. MALAYSIA PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 218. MALAYSIA PHARMACEUTICAL GELATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 219. SINGAPORE PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 220. SINGAPORE PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 221. SINGAPORE PHARMACEUTICAL GELATIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 222. SINGAPORE PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 223. SINGAPORE PHARMACEUTICAL GELATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 224. VIETNAM PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 225. VIETNAM PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 226. VIETNAM PHARMACEUTICAL GELATIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 227. VIETNAM PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 228. VIETNAM PHARMACEUTICAL GELATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 229. TAIWAN PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 230. TAIWAN PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 231. TAIWAN PHARMACEUTICAL GELATIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 232. TAIWAN PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 233. TAIWAN PHARMACEUTICAL GELATIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 234. PHARMACEUTICAL GELATIN MARKET SHARE, BY KEY PLAYER, 2024
TABLE 235. PHARMACEUTICAL GELATIN MARKET, FPNV POSITIONING MATRIX, 2024

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Pharmaceutical Gelatin market report include:
  • Darling Ingredients Inc.
  • Gelita AG
  • Nitta Gelatin Inc.
  • PB Leiner NV
  • Nippi Inc.
  • Weishardt International SAS
  • Tessenderlo Group NV
  • Danish Crown Protein A/S
  • Italgelatin SpA
  • MV Protein Inc.

Table Information